The secretome as 21st century medicine
FIRST CONFERENCE AUTONOMOUS UNIVERSITY OF MADRID AND PEACHES DEMONSTRATES THE SUCCESSFUL UNION OF OUR RESEARCH FORCES, THE ACADEMIC, UNIVERSIDAD AUTÓNOMA DE MADRID, AND THE INDUSTRY, PEACHES BIOTECH – The UAM-PEACHES Chair in Cellular Therapies at the Autonomous...
Peaches Biotech receives 598,000 euros from the CDTI for its PRS project on advanced therapies
The Center for Technological Development and Innovation (CDTI), of the Ministry of Science and Innovation, has approved a project of the Spanish company Peaches Biotech, considering it highly innovative, providing it with 598,000 euros. The selected research...
Peaches Biotech, the Universidad Autónoma of Madrid (UAM) and its Foundation create the first University Chair in Advanced Therapies
We have created with the Universidad Autónoma of Madrid (UAM) and its Foundation (FUSM) the first University Chair in Advanced Therapies based on cell secretomes The UAM-Peaches Chair will promote research and teaching in the areas of Cellular Therapy and Regenerative...
Peaches obtains financial approval from the Ministry of Science and Innovation for two of its advanced therapy projects
PRESS RELEASE Peaches has the demanding scientific and technological recognition of AEI The State Research Agency (AEI) of the Ministry of Science and Innovation approves funding for two Peaches Biotech projects in its call for public-private collaboration. The...
International Cancer Research Day
We share with you this interesting interview in Con Salud, one of the leading media in the health sector, about our novel and promising approach to pancreatic cancer treatment. Juan Carlos de Gregorio, our CEO and founder, explains in plain language the advances...
A new approach for the treatment of infection-associated cytokine storm.
Did you know that cytokine storm, associated with severe infectious processes, is a serious global health problem for which there is no effective drug for treatment? Peaches Biotech’s Chief Scientific Officer publishes results of his research against the...
“We are closer and a cure for pancreatic cancer will be feasible.”
Interview with Manuel Hidalgo, research associate at Peaches Biotech, in the supplement A tu Salud of La razón. Research talent is one of our company’s greatest assets. On this occasion, Manuel Hidalgo, Director of the Division of Hematology-Oncology at Weill...
Peaches Biotech is working on a new approach against pancreatic cancer.
Tribune published in El Economista Our CEO, Juan Carlos de Gregoriohas had the opportunity to publish in The Economist a forum where he shares his vision on the current treatments for pancreatic cancer, as well as the new approach proposed by Peaches against...